BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

PROMISCUOUS

Database for network-based drug-repositioning

PROMISCUOUS is an exhaustive resource of protein-protein and drug-protein interactions with the aim of providing a uniform data set for drug repositioning and further analysis. Our database PROMISCUOUS contains three different types of entities: drugs, proteins and side-effects. These entities are connected between each other through drug-protein, protein-protein and drug-side-effect relations.

Proteins are retrieved from UniProt and are displayed with synonyms and organism information. Additional information as 3D-structures from PDB and EC-numbers are given if available. Drugs gained from SuperDrug were integrated to PROMISCUOUS and assigned metadata as ATC-codes (Anatomical Therapeutic Chemical), structure information and synonyms. The side-effects contained in the database were fetched from SIDER and related to the drugs.


Home page of this offering

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
back to Marketplace

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.